EUVIMEDEUVIMED entdecken
Open Access

Induction of Immune Responses and Phosphatidylserine Exposure by TLR9 Activation Results in a Cooperative Antitumor Effect with a Phosphatidylserine-targeting Prodrug

Jen-Chih Tseng, Jing-Xing Yang, Chia-Yin Lee, Chen-Fu Lo, Yi-Ling Liu, Mingzi M Zhang, Li-Rung Huang, Ko-Jiunn Liu, Chien-Chia Wang, Chi-Ying F Huang, Yi-Ren Hong, Lun K Tsou und 1 weitere

International Journal of Biological Sciences · 2023

DOI: 10.7150/ijbs.81683 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2023. Verfasst von Jen-Chih Tseng und 12 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Research Center, National Health Research Institutes, Zhunan, Miaoli 35053, Taiwan. Hauptthemen laut MEDLINE: Prodrugs, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Head and neck cancer is a major cancer type, with high motility rates that reduce the quality of life of patients. Herein, we investigated the effectiveness and mechanism of a combination therapy involving TLR9 activator (CpG-2722) and phosphatidylserine (PS)-targeting prodrug of SN38 (BPRDP056) in a syngeneic orthotopic head and neck cancer animal model. The results showed a cooperative antitumor effect of CpG-2722 and BPRDP056 owing to their distinct and complementary antitumor functions. CpG-2722 induced antitumor immune responses, including dendritic cell maturation, cytokine production, and immune cell accumulation in tumors, whereas BPRDP056 directly exerted cytotoxicity toward cancer cells. We also discovered a novel function and mechanism of TLR9 activation, which increased PS exposure on cancer cells, thereby attracting more BPRDP056 to the tumor site for cancer cell killing. Killed cells expose more PS in tumor for BPRDP056 targeting. Tumor antigens released from the dead cells were taken up by antigen-presenting cells, which enhanced the CpG-272-promoted T cell-mediated tumor-killing effect. These form a positive feed-forward antitumor effect between the actions of CpG-2722 and BPRDP056. Thus, the study findings suggest a novel strategy of utilizing the PS-inducing function of TLR9 agonists to develop combinational cancer treatments using PS-targeting drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsNeoplasmsAnimalsToll-Like Receptor 9PhosphatidylserinesQuality of LifeImmunity

Stichwörter der Autor:innen

Cancer immunotherapyCpG-oligodeoxynucleotideImmunogenic cell deathPhosphatidylserine-targeting prodrugToll-like receptorTopoisomerase I inhibitor

Substanzen

Toll-Like Receptor 9PhosphatidylserinesProdrugs

Autor:innen und Institutionen

  • Immunology Research Center, National Health Research Institutes, Zhunan, Miaoli 35053, Taiwan.
  • National Institute of Cancer Research, National Health Research Institutes, Zhunan, Miaoli 35053, Taiwan.
  • Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan, Miaoli, 35053, Taiwan.
  • Institute of Molecular and Genomic Medicine, National Health Research Institutes, Zhunan, Miaoli, 35053, Taiwan.
  • Department of Life Sciences, National Central University, Zhongli District, Taoyuan City 32001, Taiwan.
  • Institute of Biopharmaceutical Sciences, College of Pharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan.

Zitieren

APA

Tseng, J. C., Yang, J. X., Lee, C. Y., Lo, C. F., Liu, Y. L., Zhang, M. M., Huang, L. R., Liu, K. J., Wang, C. C., Huang, C. F., Hong, Y. R., Tsou, L. K., & Chuang, T. H. (2023). Induction of Immune Responses and Phosphatidylserine Exposure by TLR9 Activation Results in a Cooperative Antitumor Effect with a Phosphatidylserine-targeting Prodrug. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.81683

Vancouver

Tseng JC, Yang JX, Lee CY, Lo CF, Liu YL, Zhang MM, et al. Induction of Immune Responses and Phosphatidylserine Exposure by TLR9 Activation Results in a Cooperative Antitumor Effect with a Phosphatidylserine-targeting Prodrug. International Journal of Biological Sciences. 2023. doi:10.7150/ijbs.81683

BibTeX
@article{Tseng2023,
  author = {Tseng, Jen-Chih and Yang, Jing-Xing and Lee, Chia-Yin and Lo, Chen-Fu and Liu, Yi-Ling and Zhang, Mingzi M and Huang, Li-Rung and Liu, Ko-Jiunn and Wang, Chien-Chia and Huang, Chi-Ying F and Hong, Yi-Ren and Tsou, Lun K and Chuang, Tsung-Hsien},
  title = {Induction of Immune Responses and Phosphatidylserine Exposure by TLR9 Activation Results in a Cooperative Antitumor Effect with a Phosphatidylserine-targeting Prodrug},
  journal = {International Journal of Biological Sciences},
  year = {2023},
  doi = {10.7150/ijbs.81683}
}
Kostenlos starten →